Stay updated on Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial
Sign up to get notified when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.

Latest updates to the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page
- Check5 days agoChange DetectedThe page now indicates that the study has increased to 42 locations, with a specific mention of Haifa, Israel, as a new recruiting site. Additionally, the date has been updated to reflect recent changes.SummaryDifference0.4%
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check19 days agoChange DetectedThe page has updated its location from La Jolla, California to San Diego, California, and has made revisions to the associated hospital name, now specifically referencing The Ohio State University James Cancer Hospital. Additionally, the revision number has been updated to v2.16.3.SummaryDifference0.6%
- Check26 days agoChange DetectedThe webpage has been updated to reflect new study locations and changes in eligibility criteria for a clinical trial involving the drug Cevostamab, including the addition of new cohorts and specific requirements for participants. The study is now recruiting at 41 locations, an increase from the previous 39.SummaryDifference17%
- Check33 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1.0%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.